Cheers moreld, thanks for pointing out the half yearly, other expenses might crop up.
Their latest quarterly was announced on your same link on 30th July, or by using (ASX's search for past month for PBT announcements):
http://www.asx.com.au/asx/statistics/announcementSearch.do?method=searchByCode&issuerCode=PBT&timeFrameSearchType=D&releasedDuringCode=M
and clicking on the 30th July announcement. Otherwise can email you document on your nominated account.
The big changes were reduction in the 'loss of fair valuation of financial liabilities', it spiked by 1.4M compared to year before's half yearly, however, they've also trimmed down their staff expenses.
The 8M also included their non-cash assets, their current quarter burn rate is around 2M of which they have 7.4M cash left. They've lost 0.7M+ in that half yearly on exchange rates! Is proportional, so that is reduced as well, in this latest quarter it was only a loss of 0.116M...
- Forums
- ASX - By Stock
- looking good
ATH
alterity therapeutics limited
Add to My Watchlist
5.56%
!
1.0¢

Cheers moreld, thanks for pointing out the half yearly, other...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(5.56%) |
Mkt cap ! $86.71M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 0.9¢ | $3.636K | 392.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 12135933 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 13342543 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 12135933 | 0.009 |
23 | 12766186 | 0.008 |
21 | 13152963 | 0.007 |
15 | 9028518 | 0.006 |
6 | 3460001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 13342543 | 11 |
0.011 | 14902060 | 28 |
0.012 | 15532542 | 25 |
0.013 | 8290068 | 13 |
0.014 | 14813180 | 9 |
Last trade - 11.41am 04/07/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online